BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, July 10, 2026
Home » Newsletters » BioWorld MedTech

BioWorld MedTech

Dec. 16, 2009

View Archived Issues

Panel recommends RCTs for prostate cancer treatments

GAITHERSBURG, Maryland – As some device makers tell it, enrolling patients into a randomized clinical trial (RCT) is like getting dancers on the dance floor, at least in one respect; it's tough to get someone to be the first. Unlike the accumulation of dancers on the dance floor, however, the arrival of the first enrollee in an RCT does not ensure a landslide of participation. (Medical Device Daily) Read More

ConforMIS launches next generation iUni G2 device

Read More

Report from Europe: Alcon bolsters ophthalmology segment with Optonol purchase

Read More

Court report: Luna settles with Hansen, gives up stock, $5M promissory note

Read More

Deals roundup: Covidien says $58.7M tender offer accepted by Aspect

Read More

Coming Wednesday in MDD Perspectives: The "war" on Christmas: Three lessons, no carols

Read More

Financings roundup: SBi secures $30M credit facility, funds support new products

Read More

Agreements/contracts: Corgenix, BG Medicine form supply agreement

Read More

Patent watch: Sword Diagnostics secures Raman Scattering test tech

Read More

Med-Tech Notes

Read More

Product Briefs

Read More

People in the News

Read More

MDD's Cardio Extra

Read More

New blood test may detect early-stage colon cancer

Medical researchers with EDP Biotech (Knoxville, Tennessee) say they have captured national attention with a new technology for a simple blood test designed to detect early-stage colon cancer. (Medical Device Daily) Read More

Myomo restores function in stroke patient victims

Read More

Report from Europe: Ability of cardiopoietic cells to restore cardiac function evaluated

Read More

Washington roundup: Device tax would be delayed under new Senate amendment

Read More

Deals roundup: Abbott to acquire Starlims Technologies for $123M in cash

Read More

Today's MDD food for med-tech thought

Read More

Agreements/contracts: HealthEdge partners with iWay to integrate HealthRules

Read More

Patent watch: ATS Medical gains tech to cut tissue materials for devices

Read More

Financings roundup: PatientKeeper raises $13M to help attain 'meaningful use'

Read More

Court report: 30 indicted for $61 million in fraudulent Medicare billings

Read More

Product Briefs

Read More

People in the News

Read More

MDD's Oncology Extra

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 10, 2026.
  • 3D rendering of an antibody drug conjugate

    ‘Target-high but uptake-defective’ state identified in ADC resistance

    BioWorld
    Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
  • Illustration of brain and brain waves, concept of focal seizure

    Hyperexcitability may be joint problem in epilepsy, dementia

    BioWorld
    The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
  • Modius Spero wearable neuromodulation device

    Neurovalens granted FDA approval for PTSD therapy for US veterans

    BioWorld
    Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
  • Wainua autoinjector

    Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy

    BioWorld
    News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing